Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Leases: 2019-2025

Historic Leases for UroGen Pharma (URGN) over the last 6 years, with Sep 2025 value amounting to $5.4 million.

  • UroGen Pharma's Leases rose 412.45% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 412.45%. This contributed to the annual value of $2.3 million for FY2024, which is 36.74% up from last year.
  • Per UroGen Pharma's latest filing, its Leases stood at $5.4 million for Q3 2025, which was up 24.19% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, UroGen Pharma's Leases ranged from a high of $5.4 million in Q3 2025 and a low of $945,000 during Q1 2022.
  • Its 3-year average for Leases is $2.5 million, with a median of $2.1 million in 2023.
  • Per our database at Business Quant, UroGen Pharma's Leases slumped by 65.63% in 2021 and then soared by 412.45% in 2025.
  • Quarterly analysis of 5 years shows UroGen Pharma's Leases stood at $1.2 million in 2021, then skyrocketed by 107.80% to $2.5 million in 2022, then plummeted by 31.85% to $1.7 million in 2023, then soared by 36.74% to $2.3 million in 2024, then skyrocketed by 412.45% to $5.4 million in 2025.
  • Its Leases was $5.4 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.1 million in Q1 2025.